Navigation Links
Massey Cancer Center researcher helps to identify a piece of the cancer puzzle

A structural biologist from the Virginia Commonwealth University Massey Cancer Center, in collaboration with researchers at Memorial Sloan-Kettering Cancer Center, has identified the crystal structure of a protein that plays a role in supplying nutrients to solid tumors.

This identification may help researchers gain a greater understanding of the cell signaling that occurs when cancer cells try to co-opt nearby healthy cells into helping to feed and spread growing tumors.

The structure of the protein, Ang2, will be published this week in "Structure" a peer-reviewed scientific journal.

"By examining structures of proteins and learning how they interact with each other, we can better explore how to turn off the signals that promote cancer growth," said William A. Barton, Ph.D., a VCU alumnus who recently returned to Richmond to continue his research.

"Once we understand the shape and characteristics of proteins involved in tumor growth and development, researchers can identify therapeutics that may eventually lead to cures for cancer."


'"/>

Source:Virginia Commonwealth University


Page: 1

Related biology news :

1. VCU Massey Cancer Center study shows enzyme linked to spread of breast cancer cells
2. VCU Massey Cancer Center researchers identify a new class of anti-cancer drugs based on platinum
3. Massey researchers induce cell death in leukemia
4. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
5. Jump-starting T Cells In Skin Cancer
6. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
7. Fox Chase Cancer Center scientists identify immune-system mutation
8. Breakthrough Microarray-based Technology for the Study of Cancer
9. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
10. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
11. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/7/2019)... ... January 07, 2019 , ... Concerto HealthAI, a ... precision health in oncology and other key therapeutic areas, and its Chief Executive ... entrepreneurs and executives spanning the entire healthcare landscape, on January 8, 2019, at ...
(Date:1/5/2019)... ... January 04, 2019 , ... Join Bill Fox, Chief ... Life Sciences from MarkLogic – for a live webinar on Wednesday, ... challenges of using real world data for pharmacovigilance, and the implications of current ...
(Date:1/4/2019)... WHITEHOUSE, N.J. (PRWEB) , ... January 03, 2019 ... ... to rapidly adopt 3D cell culture models into their drug discovery research workflows ... these models improve the in vivo relevancy of in vitro studies, they create ...
Breaking Biology News(10 mins):
(Date:1/15/2019)... ... January 15, 2019 , ... With the U.S. Congress designating January as Cervical ... (STD) testing service, today announces tips to help reduce the risk of Cervical Cancer. , ... (HPV). Genital HPV is the #1 most common STD and an STI that ...
(Date:1/10/2019)... ... January 08, 2019 , ... ... innovative spinal implant company, announced today that SAGICO will be represented at ... The annual J.P. Morgan Healthcare Conference is the largest and most informative ...
(Date:1/7/2019)... , ... January 07, 2019 , ... ... clinical trials of its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 is ... Disease. The trial took place in South Korea. , This Phase 1 ...
(Date:1/4/2019)... ... 2019 , ... Calidi Biotherapeutics, Inc., a clinical-stage ... the founding of a scientific and medical advisory board (SMAB). The SMAB will ... the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB include Lisa H. ...
Breaking Biology Technology: